BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Bayer AG Genzyme's small
molecule library
licensing
agreement--
Genzyme will
receive up-front
and service fees
and milestones
Copyright ©2006 AHC Media ® 177
12/97
Behringwerke AG amylase substrate licensing
agreement
11/91
Biogen Idec Inc. Avonex (interferon beta- commercialization 9/98
1a) for MS
and exclusive
distribution
agreement for
Japan
Celtrix
TGF-B2 for tissue product
6/94
Pharmaceuticals repair, treatment of MS, development,
Inc.
and other systemic licensing, and
applications
marketing
agreement through
Genzyme Tissue
Repair
Crucell NV production of
nonexclusive STAR 12/05
monoclonal antibodies research licensing
agreement
Cubist
small molecule
drug discovery 3/97
Pharmaceuticals compounds targeting alliance--Cubist will
Inc.
bacterial and fungal screen Genzyme's
infections
compound library,
once potential
therapeutic
compounds are
discovered, Cubist
and Genzyme will
negotiate
development terms
Cyclacel Group Licensing of two of option agreement 9/05
plc
Cyclacel's Cyclin-
Dependent Kinase
inhibitors
Daiichi Pure HDL cholesterol blood distribution
1/96
Chemicals Co.
Ltd.
test
agreement
De Novo
De Novo to apply its drug discovery 1/06
Pharmaceuticals molecular structure collaboration
Ltd.
generating technology
to focus on a disease
target that is of interest
to Genzyme
agreement
DiagnoCure Inc. 40 genes for potential licensing
11/05
use in detecting lung
cancer
agreement
Dyax Corp. Dyax's phage display non-exclusive 1996
patents
patent licensing
agreement,
including signing
fees, milestone
payments and
royalties, Dyax gets
access to related
patented
technology owned
by licensee
Dyax Corp. Dyax's human plasma letter of intent for 12/98
Kallikrein inhibitor (EPI- development
KAL-2)
agreement